Genome organization, virulence genes, and temperature-dependent motility of an emerging pathogen, Escherichia marmotae
Abstract
Introduction: Escherichia marmotae is one of the Escherichia cryptic clades that were first isolated from animal feces and environmental waters and has recently emerged as an organism of concern due to its presence in human infections. Although E. marmotae cannot be distinguished from E. coli by standard clinical tests, its 10% pairwise genomic difference from E. coli led us to investigate other phenotypic differences that may be present.
Methods: Bioinformatic software was used to identify the E. marmotae pan-genome, antimicrobial and virulence genes, and sequences of genes for motility, biofilm formation, and other phenotypic characteristics. Environmental and clinical isolates of E. marmotae were analyzed for antimicrobial sensitivity, and for temperature effects on motility, growth, and biofilm formation, in comparison to E. coli. RT-PCR analyzed associated changes in gene expression.
Results: The E. marmotae genome consists of >75% core genes, and has many accessory genes, including plasmids and antimicrobial resistance genes. E. marmotae is resistant to erythromycin. E. marmotae had all genes needed for complete flagellar gene assembly, and phenotypically was motile at 28°C, and much less motile at 37°C. More biofilm formation was observed at 28°C than at 37°C. The expression of motility genes motA and fliA decreased at 37°C in E. marmotae compared to E. coli.
Conclusion: These temperature-sensitive traits may support environmental persistence and adaptations that may…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.